PRISM Med-Device Index Mover: Intelligent Bio Solutions Inc. Streamlines In-House Drug Testing at Robinson Brothers; Stock Rises +11%
Intelligent Bio Solutions Inc. (Nasdaq: INBS), a renowned leader in the medical technology sector, announced today its significant contribution to modernizing the drug testing process at Robinson Brothers, a major independent chemical manufacturer in the UK. The introduction of the in-house Intelligent Fingerprinting Drug Screening System at Robinson Brothers marks a key advancement in refining their drug and alcohol testing protocols.
Key Advantages:
- Cost Efficiency: By bringing testing in-house, Robinson Brothers anticipates significant cost reductions. The initial investment in the DSR-Plus drug screening cartridge reader is offset by the lower ongoing costs of conducting tests, projected to be about half the expense of previous methods.
- Operational Flexibility: The system’s portability and ease of use are ideal for Robinson Brothers’ 24/7 operations, allowing for spontaneous and random testing, thus ensuring a safer work environment.
- Non-Intrusive Testing Method: The fingerprint-based approach offers a more hygienic and less invasive alternative to traditional testing methods, eliminating the discomfort and productivity disruptions associated with urine-based testing.
- Supporting Company Policy: The system’s visibility and simplicity help enforce the company’s Drug and Alcohol Policy, serving as an effective on-site deterrent.
Intelligent Bio Solutions Inc. is a featured company in the PRISM Emerging Med-Devices Index
About Intelligent Bio Solutions Inc.:
Intelligent Bio Solutions Inc. specializes in intelligent, rapid, non-invasive testing solutions. Their Intelligent Fingerprinting Drug Screening System, which detects drugs through fingerprint sweat analysis, represents a major advancement in workplace drug testing. This technology offers a hygienic, efficient, and cost-effective approach, with potential for broader medical applications.
